Sangamo Therapeutics
Stock Forecast, Prediction & Price Target
Sangamo Therapeutics Financial Estimates
Sangamo Therapeutics Revenue Estimates
Sangamo Therapeutics EBITDA Estimates
Sangamo Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $110.70M N/A | $111.29M 0.54% | $176.23M 58.34% | Avg: $76.33M Low: $76.33M High: $76.33M avg. -56.68% | Avg: $80.69M Low: $80.69M High: $80.69M avg. 5.70% | Avg: $204.62M Low: $204.62M High: $204.62M avg. 153.58% | Avg: $370.28M Low: $370.28M High: $370.28M avg. 80.95% |
Net Income
% change YoY
| $-178.29M N/A | $-192.27M -7.84% | $-257.83M -34.09% | Avg: $-31.15M Low: $-31.15M High: $-31.15M avg. 87.91% | Avg: $-29.31M Low: $-29.31M High: $-29.31M avg. 5.88% | Avg: $25.11M Low: $25.11M High: $25.11M avg. 185.67% | Avg: $97.68M Low: $97.68M High: $97.68M avg. 288.88% |
EBITDA
% change YoY
| $-183.33M N/A | $-201.28M -9.78% | $-87.42M 56.56% | Avg: $-69.04M Low: $-69.04M High: $-69.04M avg. 21.02% | Avg: $-72.98M Low: $-72.98M High: $-72.98M avg. -5.70% | Avg: $-185.08M Low: $-185.08M High: $-185.08M avg. -153.58% | Avg: $-334.92M Low: $-334.92M High: $-334.92M avg. -80.95% |
EPS
% change YoY
| -$1.23 N/A | -$1.25 -1.62% | -$1.48 -18.4% | Avg: -$0.18 Low: -$0.18 High: -$0.18 avg. 87.93% | Avg: -$0.17 Low: -$0.17 High: -$0.17 avg. 5.88% | Avg: $0.14 Low: $0.14 High: $0.14 avg. 185.67% | Avg: $0.56 Low: $0.56 High: $0.56 avg. 288.88% |
Operating Expenses
% change YoY
| $294.03M N/A | $312.58M 6.30% | $450.23M 44.03% | Avg: $38.45M Low: $38.45M High: $38.45M avg. -91.45% | Avg: $40.65M Low: $40.65M High: $40.65M avg. 5.70% | Avg: $103.09M Low: $103.09M High: $103.09M avg. 153.58% | Avg: $186.55M Low: $186.55M High: $186.55M avg. 80.95% |
FAQ
What is Sangamo Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 142.09% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -31.15M, average is -31.15M and high is -31.15M.
What is Sangamo Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 45.89% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $76.33M, average is $76.33M and high is $76.33M.
What is Sangamo Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 142.09% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.18, average is -$0.18 and high is $-0.17.